Article
The year 2004 has been marked by important developments in IOLs.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
AI-assisted biomarker segmentation offers precision in nAMD disease monitoring
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
50 years of visionary innovation: Leading ophthalmologists reflect on the field’s greatest breakthroughs
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
BVI Medical receives 510(k) FDA clearance for glaucoma surgical system
Regeneron’s sBLA for Eylea HD accepted for priority review by FDA